Global Protein Drugs Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. The factors that propel the growth of the industry include increasing demand, rapid urbanization & industrialization, and product development & technological innovations.
In addition, key factors such as rise in geriatric population, growing prevalence of disorders, increasing research undertakings, and awareness among people significantly contribute to the growth of Protein Drugs Market. On the other hand, there are also factors that may hamper the growth of the market such as high cost of protein drugs.
Protein Drugs Market is classified on the basis of product type, applications, distribution channel and geography. Protein Drugs Industry is segmented by product type as antibody drugs, blood products, enzymes, peptide hormones, and others. Protein Drugs Industry is classified on applications as AIDS, cancer, diabetes, hepatitis, and others. The market is segmented by distribution channel as online stores, specialty stores and others. Protein Drugs Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and African region consists of GCC, South Africa and North Africa. By geography, North America is projected to register a major share of the Protein Drugs Market. The key factors that attribute to the growth of this region include increasing demand, favorable reimbursement policies, rising prevalence of disorders, affordability and growing R&D undertakings. On the other hand, Asia Pacific is expected to show high growth rates in the Protein Drugs Market.
Some of the key players that fuel the growth of the Protein Drugs Market include Abbott Laboratories, Amgen, Bristol-Myers Squibb, Biogen Idec, Dendreon Corporation, Genentech, Eli Lilly, Johnson & Johnson, Novo Nordisk, UCB Group, Schering-Plough Corporation, and others. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
This report studies the global Protein Drugs market, analyzes and researches the Protein Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• Eli Lilly
• Abbott Laboratories
• UCB Group
• Schering-Plough Corporation
• Johnson Johnson
• Bristol-Myers Squibb
• Novo Nordisk
• Biogen Idec
• Dendreon Corporation
Market segment by Regions/Countries, this report covers
• United States
• Southeast Asia
Market segment by Type, the product can be split into
• Antibody Drugs
• Peptide Hormones
• Blood Products
Market segment by Application, Protein Drugs can be split into
Research Support Specialist, USA